Urinary Malondialdehyde as a Biomarker of Type 2 Diabetes Mellitus Treatment in the Primary Care Unit of a Tertiary Care Hospital

INTRODUCTION/OBJECTIVES: The examination of Urinary Malondialdehyde (UMDA) as a biomarker in the involvement of inflammatory response and oxidative stress, as a mechanism underlying the development of diabetes; in addition to complications in followed-up patients at a primary healthcare unit. The le...

Descripción completa

Detalles Bibliográficos
Autores principales: Choosong, Thitiworn, Chootong, Rattanaporn, Sono, Supinya, Noofong, Yupa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388219/
https://www.ncbi.nlm.nih.gov/pubmed/34427120
http://dx.doi.org/10.1177/21501327211039987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388219/
https://www.ncbi.nlm.nih.gov/pubmed/34427120
http://dx.doi.org/10.1177/21501327211039987

Ejemplares similares